Skip to main content
. 2025 Sep 19;14(18):6620. doi: 10.3390/jcm14186620
ICI Immune checkpoint inhibitor
PD-1 Programmed Death-1 Receptor
CTLA-4 Cytotoxic T Lymphocyte Associated Protein-4
PD-L1 Programmed Death Ligand-1
irAEs immune-related adverse events
ICI-DM ICI-induced diabetes mellitus